Nabilone

Cannabis Drugs Market Size to Surpass US$ 2013.42 Billion by 2030 | Exclusive Report by Growth Plus Reports

Retrieved on: 
Thursday, October 6, 2022

The increased cannabis approvals by regulatory bodies for medicinal use, rising availability of cannabis drugs in online pharmacy, and more and more physicians prescribing cannabis for medical and recreational purposes is driving the global cannabis drugs market.

Key Points: 
  • The increased cannabis approvals by regulatory bodies for medicinal use, rising availability of cannabis drugs in online pharmacy, and more and more physicians prescribing cannabis for medical and recreational purposes is driving the global cannabis drugs market.
  • The global cannabis drugs market has been analyzed from three different perspectives brand, application, and region.
  • Download PDF Brochure of Cannabis Drugs Market Size - COVID-19 Impact and Global Analysis with Strategic Developments at: https://growthplusreports.com/inquiry/request-sample/cannabis-drugs-mark...
    The global cannabis drugs market has been divided into four approved brands namely:
    The largest revenue share was accounted for by the Epidiolex brand segment, which dominated the market for cannabis medications and is predicted to increase at the fastest rate over the forecasted period.
  • The prominent players operating in the global cannabis drugs market:

Cannabis Drugs Market Size to Surpass US$ 2013.42 Billion by 2030 | Exclusive Report by Growth Plus Reports

Retrieved on: 
Thursday, October 6, 2022

The increased cannabis approvals by regulatory bodies for medicinal use, rising availability of cannabis drugs in online pharmacy, and more and more physicians prescribing cannabis for medical and recreational purposes is driving the global cannabis drugs market.

Key Points: 
  • The increased cannabis approvals by regulatory bodies for medicinal use, rising availability of cannabis drugs in online pharmacy, and more and more physicians prescribing cannabis for medical and recreational purposes is driving the global cannabis drugs market.
  • The global cannabis drugs market has been analyzed from three different perspectives brand, application, and region.
  • Download PDF Brochure of Cannabis Drugs Market Size - COVID-19 Impact and Global Analysis with Strategic Developments at: https://growthplusreports.com/inquiry/request-sample/cannabis-drugs-mark...
    The global cannabis drugs market has been divided into four approved brands namely:
    The largest revenue share was accounted for by the Epidiolex brand segment, which dominated the market for cannabis medications and is predicted to increase at the fastest rate over the forecasted period.
  • The prominent players operating in the global cannabis drugs market:

Global Medical Marijuana Market Trends/Analysis Report 2022: A $65.8 Billion Industry by 2030 - Rapid Adoption of Cannabis in Therapeutic Applications - ResearchAndMarkets.com

Retrieved on: 
Tuesday, October 4, 2022

The major factors attributed to the industry growth are the rapid adoption of cannabis in therapeutic applications and a surge in the number of countries legalizing the usage of medical marijuana.

Key Points: 
  • The major factors attributed to the industry growth are the rapid adoption of cannabis in therapeutic applications and a surge in the number of countries legalizing the usage of medical marijuana.
  • As per numerous studies, cannabis has shown positive results in the treatment of chronic diseases.
  • Thus, with the growing penetration of chronic disease throughout the globe, the industry is expected to see a steep rise in demand.
  • For instance, as per the data released by the WHO, the chronic disease burden was expected to reach 57% by 2020.

Second Edition Pharmaceutical Cannabis Report 2021: Featuring Almirall, Bayer and Novartis Among Others - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 23, 2021

Global surveys of cannabis users indicate that around 40% of users have some medical component to their usage.

Key Points: 
  • Global surveys of cannabis users indicate that around 40% of users have some medical component to their usage.
  • The use of cannabinoids in the treatment of medical conditions offers major opportunities, but also challenges to anyone operating in the space.
  • In Europe however, there is a clear trend towards the use of more precise formulations of unapproved cannabis products as well as approved pharmaceutical products.
  • Many in the medical cannabis space are developing portfolios of patents to protect products and their methods of production.

Ault Global Holdings Announces Adtech Pharma, Inc., an Innovative Biotech, Appoints Jodi Brichan to Its Board of Directors

Retrieved on: 
Monday, September 27, 2021

Ault Global Holdings, Inc. (NYSE American: DPW) a diversified holding company (the Company), announced that Adtech Pharma, Inc. (Adtech), has appointed Jodi Brichan, to its Board of Directors.

Key Points: 
  • Ault Global Holdings, Inc. (NYSE American: DPW) a diversified holding company (the Company), announced that Adtech Pharma, Inc. (Adtech), has appointed Jodi Brichan, to its Board of Directors.
  • Milton Todd Ault, III, the Companys Executive Chairman, stated, We are very pleased that Adtech has appointed Jodi Brichan to its board of directors.
  • Dr. Robert Kupper, President and CEO of Adtech stated, We are very pleased to have appointed Jodi Brichan to our board of directors.
  • Ault Global Holdings, Inc. is a diversified holding company pursuing growth by acquiring undervalued businesses and disruptive technologies with a global impact.